Feline Plasma Cell Pododermatitis: Welfare Management

Plasma cell pododermatitis (pillow foot) is a painful immune-mediated condition affecting cat paw pads, with welfare improvements achievable through immunosuppressive treatment.

Key Facts

Plasma cell pododermatitis causes soft, swollen, sometimes ulcerated paw pads — the condition affects one or more feet
The underlying cause is immune-mediated — plasma cell infiltration into the dermis causes the characteristic soft swelling
Doxycycline is the primary treatment and achieves remission in many cases; some cats require indefinite treatment to prevent relapse
The condition can be painful and causes lameness in severe cases with ulcerated or fractured pads

Welfare Considerations

Pillow foot welfare impacts range from minimal (soft pads without ulceration causing no apparent discomfort) to significant (painful, fractured pads causing lameness and reluctance to walk). The welfare urgency varies with severity — ulcerated pads require prompt treatment while mild cases may be monitored. Doxycycline achieves remission in a majority of cases within 8-12 weeks, often with sustained welfare improvement. Relapse after treatment cessation is common, and long-term low-dose maintenance therapy is often required for sustained welfare benefit.

What You Can Do

Begin doxycycline treatment at 10 mg/kg daily and continue for minimum 8 weeks before assessing response
Monitor pad condition weekly during treatment — improvement typically begins within 4-6 weeks
Protect severely ulcerated pads with soft bandaging and analgesia during the initial treatment period
Discuss long-term maintenance therapy with your veterinarian if relapse occurs after treatment withdrawal